Federal award (DEFINITIVE CONTRACT, fiscal year 2023)
Recipient: EVALUATE LIMITED
Awarding agency: Federal Trade Commission / Federal Trade Commission
Funding agency: Federal Trade Commission / Federal Trade Commission
Period of performance: 2024-09-27 to 2025-09-26
Current total value of award: $23000
Description: EVALUATE PHARMA SUBSCRIPTION